Volume 26, Issue 4 (Winter 2019)                   J Birjand Univ Med Sci. 2019, 26(4): 372-375 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Azdaki N, Moezi Bady S A, Soltani M, Rahimi S M, Kazemi T, Khazaei Z. The Necessity of Preventing Venous Thromboembolism in Pregnancy: Designing an Application Software. J Birjand Univ Med Sci.. 2019; 26 (4) :372-375
URL: http://journal.bums.ac.ir/article-1-2718-en.html
1- Cardiovascular Diseases Research Center, Department of Cardiology , School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
2- Cardiovascular Diseases Research Center, Department of Cardiology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
3- Razi Clinical Research Development Unit (RCRDU), Birjand University of Medical Sciences, Birjand, Iran
4- Computer expert, Birjand University of Medical Sciences, Birjand, Iran
5- Cardiovascular Diseases Research Center, Department of Cardiology , School of Medicine, Birjand University of Medical Sciences, Birjand, Iran. , drtooba.kazemi@gmail.com
6- Department of Obstetrics, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Abstract:   (2488 Views)
The Venous thromboembolism (VTE), including venous thrombosis (DVT) and pulmonary embolism(PE) and one of the causes of death during the pregnancy. During the pregnancy, Multiple changes to the motherchr('39')s coagulation system lead to high coagulation. The results have shown that approximately 1 in every 200-500 women during the pregnancy with venous thromboembolism and 30% in those with pulmonary embolism. During the third trimester of pregnancy, and especially during the first two weeks after childbirth, the risk of (VTE) increases in women. The risk of VTE after pregnancy is 5 times higher than that of the  during pregnancy. Also, Pregnancy alone is a risk factor for VTE, And, besides, some women have a high risk of developing the VTE. The most important risk factors for VTE during pregnancy include the previous history of VTE, acquired thrombophilia, history of previous VTE due to major surgery, Medical problems (including cancer, heart disease, etc.), hereditary thrombophilia are high risk (Table 1).
Due to numerous clinical conditions and also the risks of an embryo and mother seeking anticoagulant therapy, management during pregnancy should be taken into consideration. Therefore, according to the latest instructions from the Ministry of Health and Medical Education, it was decided to design the software in order to prevent the occurrence of VTE.
 
Full-Text [PDF 186 kb]   (557 Downloads)    
Type of Study: Letter to the Editor | Subject: Gynecology & Obstetrics
Received: 2019/08/8 | Accepted: 2019/12/15 | ePublished: 2019/12/15

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2021 All Rights Reserved | Journal of Birjand University of Medical Sciences

Designed & Developed by : Yektaweb